Inhibition of Homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5085-5088

  Soldatenkov, Viatcheslav A ^a   Dritschilo, Anatoly ^a   Ronai, Ze'ev ^b   Fuchs, Serge Y ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOHEXIMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; PROTEIN HOS; TRANSDUCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IONIZING RADIATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; ULTRAVIOLET RADIATION;

APOPTOSIS; BETA CATENIN; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; CARRIER PROTEINS; CISPLATIN; CYCLOHEXIMIDE; CYTOSKELETAL PROTEINS; HUMANS; MELANOMA; NF-KAPPA B; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032697558     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Serrone, L., and Hersey, P. The chemoresistance of human malignant melanoma: an update. Melanoma Res., 9: 51-58, 1999.
2. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. NF-κB antiapoptosis: induclion of TRAF1 and TRAF2 and c-IAP1 and C-1AP2 to suppress caspase-8 activation. Science (Washington DC), 281: 1680-1683, 1998.
3. LaCasse, E. C., Baird, S., Korneluk, R. G., and MacKenzie, A. E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17: 3247-3259, 1998.
4. Zong, W. X., Edelstein, L. C., Chen, C., Bash, J., and Gelinas, C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev., 13: 382-387, 1999.
5. Stancovski, I., and Baltimore, D. NF-κB activation: the IκB kinase revealed? Cell. 91: 299-302, 1997.
6. Verma, I. M., and Stevenson, J. IκB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA, 94: 11758-11760, 1997.
7. Devalaraja, M. N., Wang, D. Z., Ballard, D. W., and Richmond, A. Elevated constitutive IκB kinase activity and IκBα phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GROα transcription. Cancer Res., 59: 1372-1377, 1999.
8. Bakker, T. R., Reed, D., Renno, T., and Jongeneel, C. V. Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int. J. Cancer, 80: 320-323, 1999.
9. Wang, C. Y., Cusack, J. C., Jr., Liu, R., and Baldwin, A. S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med., 5: 412-417, 1999.
10. Paillard, F. Induction of apoptosis with IκB, the inhibitor of NF-κB. Hum. Gene Ther., 10: 1-3, 1999.
11. Fuchs, S. Y., Chen, A., Xiong, Y., Pan, Z. Q., and Ronai, Z. HOS, a human homologue of Slimb, forms an SCF complex with Skpl and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin. Oncogene, 18: 2039-2046, 1999.
12. Tan, P., Fuchs, S. Y., Wu, K., Chen, A., Gomez, C., Ronai, Z., and Pan, Z-Q. Recruitment of a ROCl: cullin1 heterodimeric ubiquitin ligase by Skp1 and F box protein HOS to catalyze the phosphorylation-dependent ubiquitination of IκBα. Mol. Cell, 3: 527-534, 1999.
13. Laney, J. D., and Hochstrasser, M. Substrate targeting in the ubiquitin system. Cell, 97: 427-430, 1999.
14. Mizushima, S., and Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18: 5322, 1990.
15. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
16. Soldatenkov, V. A., and Dritschilo, A. Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. Cancer Res., 57: 3881-3885, 1997.
17. Damalas, A., Ben-Ze'ev, A., Simcha, I., Shtutman, M., Leal, J. F., Zhurinsky, J., Geiger, B., and Oren, M. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J., 18: 3054-3063, 1999.
18. Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., and Ballard, D. W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell Biol, 15: 2809-2818, 1995.
19. Xu, Y., Bialik, S., Jones, B. E., Iimuro, Y., Kitsis, R. N., Srinivasan, A., Brenner, D. A., and Czaja, M. J. NF-κB inactivation converts a hepatocyte cell line TNFα response from proliferation to apoptosis. Am. J. Physiol., 275: C1058-C1066, 1998.
20. Li, G., Tang, L., Zhou, X., Tron, V., and Ho, V. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent. Melanoma Res., 8: 17-23, 1998.